Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).
Puoti C, Castellacci R, Montagnese F, Zaltron S, Stornaiuolo G, Bergami N, Bellis L, Precone DF, Corvisieri P, Puoti M, Minola E, Gaeta GB. Puoti C, et al. Among authors: castellacci r. J Hepatol. 2002 Jul;37(1):117-23. doi: 10.1016/s0168-8278(02)00101-0. J Hepatol. 2002. PMID: 12076870
Prediction of histology in hepatitis C.
Puoti C, Castellacci R, Montagnese F, Bellis L, Festuccia F, Corvisieri P. Puoti C, et al. Among authors: castellacci r. Hepatology. 2003 Apr;37(4):950-1; author reply 951. doi: 10.1053/jhep.2003.50163. Hepatology. 2003. PMID: 12668994 No abstract available.
HCV carriers with persistently normal aminotransferase levels.
Puoti C, Bellis L, Castellacci R, Montagnese F, Bergami N, Petrone De Luca P. Puoti C, et al. Among authors: castellacci r. Hepatology. 2004 Jul;40(1):266-7; author reply 267-8. doi: 10.1002/hep.20311. Hepatology. 2004. PMID: 15239112 No abstract available.
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
Foster GR, Coppola C, Derbala M, Ferenci P, Orlandini A, Reddy KR, Tallarico L, Shiffman ML, Ahlers S, Bakalos G, Hassanein T; GUARD-C Study Group. Foster GR, et al. PLoS One. 2016 Mar 28;11(3):e0151703. doi: 10.1371/journal.pone.0151703. eCollection 2016. PLoS One. 2016. PMID: 27018988 Free PMC article. Clinical Trial.